
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives
Aja Badgeley, Hina Anwar, Karan Modi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188494-188494
Closed Access | Times Cited: 149
Aja Badgeley, Hina Anwar, Karan Modi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188494-188494
Closed Access | Times Cited: 149
Showing 1-25 of 149 citing articles:
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 172
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 172
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
Jindong Xie, Manqing Liu, Xinpei Deng, et al.
iMeta (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 31
Jindong Xie, Manqing Liu, Xinpei Deng, et al.
iMeta (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 31
Gut microbiota and endometrial cancer: research progress on the pathogenesis and application
Weiqin Zheng, Xiaowen Lin, Huixin Chen, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 3
Weiqin Zheng, Xiaowen Lin, Huixin Chen, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 3
Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury
Yangyang Li, Yiming Zhang, Kong-Xi Wei, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 83
Yangyang Li, Yiming Zhang, Kong-Xi Wei, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 83
Chemotherapy-Induced Intestinal Microbiota Dysbiosis Impairs Mucosal Homeostasis by Modulating Toll-like Receptor Signaling Pathways
Ling Wei, Xue-sen Wen, Cory J. Xian
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9474-9474
Open Access | Times Cited: 83
Ling Wei, Xue-sen Wen, Cory J. Xian
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9474-9474
Open Access | Times Cited: 83
Characteristics of Probiotic Preparations and Their Applications
Guangqiang Wang, Yunhui Chen, Yongjun Xia, et al.
Foods (2022) Vol. 11, Iss. 16, pp. 2472-2472
Open Access | Times Cited: 65
Guangqiang Wang, Yunhui Chen, Yongjun Xia, et al.
Foods (2022) Vol. 11, Iss. 16, pp. 2472-2472
Open Access | Times Cited: 65
Engineered probiotics
Junheng Ma, Yuhong Lyu, Xin Liu, et al.
Microbial Cell Factories (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 63
Junheng Ma, Yuhong Lyu, Xin Liu, et al.
Microbial Cell Factories (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 63
Recent advances in the design and fabrication of probiotic delivery systems to target intestinal inflammation
Zhaowei Jiang, Moting Li, David Julian McClements, et al.
Food Hydrocolloids (2021) Vol. 125, pp. 107438-107438
Closed Access | Times Cited: 61
Zhaowei Jiang, Moting Li, David Julian McClements, et al.
Food Hydrocolloids (2021) Vol. 125, pp. 107438-107438
Closed Access | Times Cited: 61
Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders
Senthilkumar Sankararaman, Kimberly Janelle Noriega, Sujithra Velayuthan, et al.
Current Gastroenterology Reports (2022) Vol. 25, Iss. 2, pp. 31-44
Closed Access | Times Cited: 50
Senthilkumar Sankararaman, Kimberly Janelle Noriega, Sujithra Velayuthan, et al.
Current Gastroenterology Reports (2022) Vol. 25, Iss. 2, pp. 31-44
Closed Access | Times Cited: 50
The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study
Haixiao Jiang, Wei Zeng, Xiaoli Zhang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7846-7858
Open Access | Times Cited: 46
Haixiao Jiang, Wei Zeng, Xiaoli Zhang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7846-7858
Open Access | Times Cited: 46
Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies
Min Zhou, Yucheng Tang, Wenjie Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Min Zhou, Yucheng Tang, Wenjie Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Piero Portincasa, Mohamad Khalil, Annarita Graziani, et al.
European Journal of Internal Medicine (2023) Vol. 119, pp. 13-30
Closed Access | Times Cited: 29
Piero Portincasa, Mohamad Khalil, Annarita Graziani, et al.
European Journal of Internal Medicine (2023) Vol. 119, pp. 13-30
Closed Access | Times Cited: 29
Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets
Haixiao Jiang, Wei Zeng, Xiaoli Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 11
Haixiao Jiang, Wei Zeng, Xiaoli Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 11
Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope?
Pengfei Zhang, Dan Xie
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Pengfei Zhang, Dan Xie
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Synergistic Interactions Between Probiotics and Anticancer Drugs: Mechanisms, Benefits, and Challenges
Babak Pezeshki, Hussein T. Abdulabbas, Asma M. Alturki, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 1
Babak Pezeshki, Hussein T. Abdulabbas, Asma M. Alturki, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 1
The frontier of health: Exploring therapeutic potentials of the microbiome
Mohammad Abavisani, Sobhan Karbas Foroushan, Prashant Kesharwani, et al.
PharmaNutrition (2025), pp. 100435-100435
Closed Access | Times Cited: 1
Mohammad Abavisani, Sobhan Karbas Foroushan, Prashant Kesharwani, et al.
PharmaNutrition (2025), pp. 100435-100435
Closed Access | Times Cited: 1
Acupuncture ameliorates breast cancer-related fatigue by regulating the gut microbiota-gut-brain axis
Zhuan Lv, Ruidong Liu, Kaiqi Su, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 32
Zhuan Lv, Ruidong Liu, Kaiqi Su, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 32
Role of metabolites derived from gut microbiota in inflammatory bowel disease
Lie Zheng, Xin-Li Wen, Sheng-Lei Duan
World Journal of Clinical Cases (2022) Vol. 10, Iss. 9, pp. 2660-2677
Open Access | Times Cited: 31
Lie Zheng, Xin-Li Wen, Sheng-Lei Duan
World Journal of Clinical Cases (2022) Vol. 10, Iss. 9, pp. 2660-2677
Open Access | Times Cited: 31
Dietary and microbiome evidence in multiple myeloma and other plasma cell disorders
Urvi A. Shah, Richa Parikh, Francesca Castro, et al.
Leukemia (2023) Vol. 37, Iss. 5, pp. 964-980
Open Access | Times Cited: 20
Urvi A. Shah, Richa Parikh, Francesca Castro, et al.
Leukemia (2023) Vol. 37, Iss. 5, pp. 964-980
Open Access | Times Cited: 20
Akkermansia muciniphila: A potential target and pending issues for oncotherapy
Xu Zhao, Juanjuan Zhao, Dongmei Li, et al.
Pharmacological Research (2023) Vol. 196, pp. 106916-106916
Open Access | Times Cited: 20
Xu Zhao, Juanjuan Zhao, Dongmei Li, et al.
Pharmacological Research (2023) Vol. 196, pp. 106916-106916
Open Access | Times Cited: 20
Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study
Mingdong Wang, Xiang Gao, Quan Yongjun, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Mingdong Wang, Xiang Gao, Quan Yongjun, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Gut microbiota-based pharmacokinetic-pharmacodynamic study and molecular mechanism of specnuezhenide in the treatment of colorectal cancer targeting carboxylesterase
Hang Yu, Hui Xu, Xinyu Yang, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 9, pp. 1024-1040
Open Access | Times Cited: 17
Hang Yu, Hui Xu, Xinyu Yang, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 9, pp. 1024-1040
Open Access | Times Cited: 17
Gut Microbiota is Associated with Aging‐Related Processes of a Small Mammal Species under High‐Density Crowding Stress
Xiaoming Xu, Guoliang Li, Da Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 14
Open Access | Times Cited: 16
Xiaoming Xu, Guoliang Li, Da Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 14
Open Access | Times Cited: 16
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xiaoyu Xue, Rui Li, Zhenni Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Xiaoyu Xue, Rui Li, Zhenni Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Probiotics and Probiotic-like Agents against Chemotherapy-Induced Intestinal Mucositis: A Narrative Review
Laura López‐Gómez, Alexandra Alcorta, Raquel Abalo
Journal of Personalized Medicine (2023) Vol. 13, Iss. 10, pp. 1487-1487
Open Access | Times Cited: 16
Laura López‐Gómez, Alexandra Alcorta, Raquel Abalo
Journal of Personalized Medicine (2023) Vol. 13, Iss. 10, pp. 1487-1487
Open Access | Times Cited: 16